Full Heparin Reversal With Protamine After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

Aug 8, 2026 by in CARDIOLOGY Comments Off on Full Heparin Reversal With Protamine After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis
Protamine sulfate is widely used to reverse unfractionated heparin during transfemoral transcatheter aortic valve replacement (TAVR), but the optimal reversal strategy remains uncertain. We conducted a systematic review and meta-analysis…
read more

Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease Versus Predominant Aortic Stenosis

Aug 8, 2026 by in CARDIOLOGY Comments Off on Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease Versus Predominant Aortic Stenosis
Abstract We sought to evaluate survival of patients with mixed aortic valve disease (MAVD) versus predominant aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). This was a study-level meta-analysis…
read more

Prognostic Significance of Echocardiographic Transaortic Flow Rate in Aortic Valve Stenosis: A Systematic Review and Meta-Analysis

Aug 8, 2026 by in CARDIOLOGY Comments Off on Prognostic Significance of Echocardiographic Transaortic Flow Rate in Aortic Valve Stenosis: A Systematic Review and Meta-Analysis
Echocardiographic evaluation of Aortic valve stenosis (AS) severity relies on aortic valve area and peak jet velocity. In pursuit of improving accuracy, the transaortic flow rate (FR), defined as the…
read more

Fractional Flow Reserve Versus Intravascular Imaging to Guide Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Aug 8, 2026 by in CARDIOLOGY Comments Off on Fractional Flow Reserve Versus Intravascular Imaging to Guide Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
Coronary artery disease (CAD) is a leading cause of morbidity and mortality globally, driving advancements in technology to optimize percutaneous coronary intervention (PCI) outcomes. Fractional flow reserve (FFR) provides a…
read more

The “Block the Main Way” Technique for Left Ventricular Lead Implantation in Cardiac Resynchronization Therapy: A Case Report

Aug 8, 2026 by in CARDIOLOGY Comments Off on The “Block the Main Way” Technique for Left Ventricular Lead Implantation in Cardiac Resynchronization Therapy: A Case Report
This case details the successful application of the Block the Main Way (BMW) technique to implant a left ventricular (LV) lead into an anomalously opening lateral vein during Left Bundle…
read more

Progressive Conduction System Disease in Hydroxychloroquine Cardiotoxicity: A Call for Early Vigilance

Aug 8, 2026 by in CARDIOLOGY Comments Off on Progressive Conduction System Disease in Hydroxychloroquine Cardiotoxicity: A Call for Early Vigilance
Hydroxychloroquine (HCQ) cardiotoxicity is increasingly recognized, yet progressive conduction system disease remains underappreciated and may represent a lethal phenotype. We report a 67-year-old female on chronic HCQ who developed progressive…
read more

Efficacy and Safety of Drug-Coated Balloons Alone Versus Combined With Provisional Stenting for Complex Femoropopliteal Artery Lesions

Aug 8, 2026 by in CARDIOLOGY Comments Off on Efficacy and Safety of Drug-Coated Balloons Alone Versus Combined With Provisional Stenting for Complex Femoropopliteal Artery Lesions
Complex femoropopliteal artery (FPA) lesions often require provisional stenting after suboptimal drug-coated balloon (DCB) angioplasty. This study compared midterm efficacy and safety of DCB alone versus DCB with provisional bare-metal…
read more

Primary Percutaneous Coronary Intervention is Associated with Improved Survival for Inpatient-Onset STEMI Across All Age Groups

Aug 8, 2026 by in CARDIOLOGY Comments Off on Primary Percutaneous Coronary Intervention is Associated with Improved Survival for Inpatient-Onset STEMI Across All Age Groups
The occurrence of ST-elevation myocardial infarction (STEMI) in a patient hospitalized for a noncardiac condition (inpatient STEMI; IPS) has a mortality rate that is 4– 10 fold higher than observed…
read more

Secondary Erythrocytosis in Patients With Heart Failure on SGLT2 Inhibitors: Insights from a Multicenter “Real World” Study

Aug 8, 2026 by in CARDIOLOGY Comments Off on Secondary Erythrocytosis in Patients With Heart Failure on SGLT2 Inhibitors: Insights from a Multicenter “Real World” Study
Sodium glucose cotransporter 2 inhibitors (SGLT2-i) are one of the four pillars of guideline-directed medical therapy in all patients with heart failure according to the current guidelines. Although SGLT2-i are…
read more
Get Clinical Tree app for offline access